CME Portal
CME Certificate and Information
Online Education
AVAHO Learning Center (LMS)
ONGOING OPPORTUNITIES
These educational resources are provided to you through partnerships with other educational organizations and are not AVAHO-developed education.
Subtype-Driven Therapy in DLBCL: The Emerging Role of Frontline BTK Inhibition
CME | 1.00 Credit
Time to Complete: 1 hour
Released: November 18, 2025
Expires: November 18, 2026
Learning Objectives:
- Critically examine the recent evidence supporting genetic testing for precision medicine in DLBCL.
- Discuss current applications of gene expression profiling for individuals with DLBCL who are treated in the community and VA settings.
- Assess the evidence supporting the efficacy and safety of individualized frontline regimens incorporating targeted BTKi therapies for patients with DLBCL.
- Design treatment strategies that include targeted therapies, are tailored to individual characteristics, and are applicable to the community or VA settings.
How To Claim CE:
- Watch the entire presentation.
- Complete the online evaluation form.
- Print your certificate.
If you have any questions, please contact info@plexuscomm.com.
Provided by PleXus Communications